AMPLIFON | Stock ComparatorAMPLIFON
None
Overview
Sector
Medical Distribution
Strengths
- With an appreciation Potential of 33.51%, based on our fundamental analysis, it suggests the stock may be undervalued.
- Price to book ratio (2.67) is lower than the sector mean (35.33).
- EV/EBITDA (7.21) is lower than the sector mean (40.52).
- EV/EBIT (15.69) is lower than the sector mean.
- Price to free cash flow (10.09) is lower than the sector mean.
- Strong EBITDA Margin of 23.01%.
Weaknesses
- No significant weaknesses identified based on the analyzed metrics.
Key Financial Data
| Indicator | Value |
|---|
| PER | 20.8 |
| EV/EBITDA | 7.1 |
| Price/Free Cash Flow' | 9.9 |
| ROIC | 19.1% |
| Net Debt/EBITDA |